The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical product developers regarding their efforts toward the translational development of therapeutic compounds into clinical drug candidates for treatment of diseases on the NIAID Category A, B and C Priority Pathogens list.
Specifically sought are discovery and development efforts for broad-spectrum antibacterials with emphasis on targeting antimicrobial resistant strains, as well as broad-spectrum antivirals and small molecule antitoxins. The therapeutic agent may be active against pathogen-specific targets, or target pathways necessary for pathogenesis, including host factors and responses that contribute to disease progression.
Further details are available under Solicitation Number: NIH-AI-2014007.
